chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Neck muscles feels stretched with second dose.  Started around 2 hrs after vaccination and disappeared on its own around 5 hrs.  Also had general insomnia the first night, no fever so far. No meds have been taken.
itchiness and 2 inch red welt at injection site noticed 8 days after vaccine received  applied benadryl cream for 2 days and it is fading to lighter pink
Edema near lymph nodes under arm in which vaccine was injected.  Noticed this after Monday morning swim while showering and swelling has persisted
Pt was in seated position in a chair and slumped over to right side and fell to floor.  Pt appeared to twitch slowly for aobut 20 seconds.  Pt was brought to seated position on floor. Appeared pale and diaphoretic.  Pt verbalized he did not realize he fainted and loss consciousness for about 20-50 seconds.  BP: 67/27. HR: 36. MDP doctor called over to assess situation.  2nd set of vitals taken. BP 51/27.  HR 41.  Pt given water. States he feels dizzy and light headed. Vision is "weird."  Sees colors more vibrantly. The Dr. recommends pt go to ED.  Pt transported via wheelchair by the Dr and clinic NP with Anaphylaxis kit. In ED, pt's BP was 86/60.  Blood Sugar 91.  Pt admitted for fluid hydration and monitoring.
Headache; Joints ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and ARTHRALGIA (Joints ache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HEADACHE (Headache) and ARTHRALGIA (Joints ache). On 18-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, ARTHRALGIA (Joints ache) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Patient has taken Advil and Diclofenac Gel that was available at home
Patient indicates that after 5 days after administration started feeling headaches, body aches. Test results indicate Positive to COVID-19.
ACHING IN BILATERAL HANDS; CHILLS; FEVER; HEADACHE; NAUSEA; NO TASTE; DIZZINESS; ARM FEELS HEAVY; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight was 145 pounds, and height was 62 inches. The patient's past medical history included glaucoma, and concurrent conditions included no known drug allergies, nonsmoker, non alcohol user, and no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced no taste. On 25-MAR-2021, the subject experienced dizziness. On 25-MAR-2021, the subject experienced arm feels heavy. On 25-MAR-2021, the subject experienced aching in bilateral hands. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced fever. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea on 26-MAR-2021, and had not recovered from fever, no taste, chills, headache, arm feels heavy, dizziness, and aching in bilateral hands. This report was non-serious.
About a week after the injection, there was noticeable swelling around my nose, and lower left side of my face in the evening. The next  morning the injection site swelled enormously (about the size of a baseball) was red, hot, painful and sensitive to the touch.  A descending dosage for a week of Prednisone was prescribed, and remedied the reaction.
This case was reported by a healthcare professional and described the occurrence of incorrect route of drug administration in an adult female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent vaccination included Salmonella Vi capsular polysaccharide vaccine given on an unspecified date. There were no concurrent medications. On 2 November 2008, between 09:00 and 16:00, the subject received a dose of FLULAVAL 0.5 ml, subcutaneously. This was the incorrect route of drug administration. FLULAVAL should have been administered intramuscularly. Within 12 to 24 hours following injection of FLULAVAL, the subject experienced injection site pain, redness and swelling. At the time of reporting, the events were improved. In the reporter's opinion, the events were probably related to treatment with FLULAVAL. The reported stated that approximately 200 adults were vaccinated with FLULAVAL via deep subcutaneous injection during a flu clinic. Out of these 200 plus subjects, four females reported local reactions of pain, redness and swelling within 12 to 24 hours of vaccination. One of these subjects was seen by the on-site physician who diagnosed it as a secondary infection and treated it with antibiotics and TYLENOL. It was reported that the adverse events were improving, but unknown if they resolved. Linked cases include: A0759176A, A0759188A, A0759189A, A07159190A
Severe chills, muscle aches and fever of 103.2 as indicated by my digital thermometer
MEDICATION ERROR/PARTIAL DOSING; OFF LABEL USE AS A BOOSTER AFTER COMPLETING A SERIES OF PFIZER VACCINE; This spontaneous report received from a health care professional concerned a 74 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204B21A, expiry: 11-DEC-2021) 0.3 ml, administered on 30-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-SEP-2021, the patient experienced medication error/partial dosing. On 30-SEP-2021, the patient experienced off label use as a booster after completing a series of pfizer vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the medication error/partial dosing and off label use as a booster after completing a series of pfizer vaccine was not reported. This report was non-serious.
Pt devel an urticarial rash on different parts of the body 24 hrs following DTP/OPV/HIB; the rash come & go as described by mom;
Fever- 100.5 degrees, moderate chills, diarrhea, back pain especially near left scapula (injection was on left upper arm). Symptoms lasted 24 hours
Area of erythema and warmth at injection site - approximately 4 cm diameter persisted > 72 hours. Treatment with KEFLEX.
Dizziness, Headache, Myalgia, Arthralgia, Fever, high temps reaching 104.7, muscle/joint pain, migraine, blurred vision, chills, weakness and severe dizziness ETC.  Narrative: high temps reaching 104.7, muscle/joint pain, migraine, blurred vision, chills, weakness and severe dizziness ETC.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 07Apr2022 as dose 3 (booster), single (Lot number: FK9895) at the age of 56 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 03Nov2021 as dose 2, single (Lot number: 939904), in left arm and on 14Sep2022 as dose 4 (booster), single (Lot number: AS7143C), in left arm for covid-19 immunisation; covid-19 vaccine nrvv ad26 (jnj 78436735) (JANSSEN COVID-19 VACCINE), on 10Mar2021 as dose 1, single (Lot number: 1805022), in left arm for covid-19 immunisation. The patient's relevant medical history included: "breast cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19 included Paxlovid from 07Oct2023 to 12Oct2023.
Headache, Myalgia, Fever, NauseaVomiting, night sweats, malaise Narrative:
Myalgia, Fever, chills, sore throat Narrative:  Other Medical History:
12 hrs after injection, experienced heart palpations, rapid pulse; then after 2nd dose on Feb 10, 2021, had 24 hours of severe chills, felt really bad; about three weeks later, started having very slight chest pain; first noticed it at night in bed; at present my symptoms include increased pulse rate, increased blood pressure, chest pain, chest soreness under pressure, difficulty sleeping on my left side sometimes, chest soreness when I move my upper torso a certain way, burning sensation in center of chest, left side of upper chest seems slightly bigger than right, like it is slightly swollen
Information has been received from a nurse practitioner, concerning an unspecified number of patients who were vaccinated IM with a dose, 0.5 mL, of Gardasil vaccine (lot #657621/0387U or 657736/0389U) (dates not provided), and experienced "stinging" when vaccinated. At the time of this report the outcome of the event was unknown. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Initail and follow-up information has been received froma nurse practitioner, concerning "several" female patients who were vaccinated IM with a dose, 0.5 ml of HPV vaccine (lot # 657621/0387U or 657716/0389U) (dates not provided), and experienced "stinging" when vaccinated. At the time of this report the outcome of the event was unknown. This is one of several reports received from the same source. Addiitonal information has been requested.
Fever peaking at 102.2 Muscle ache Headache Fatigue Joint pain Swollen lymph node Swelling at injection site   Acetaminophen given Symptoms ongoing 48 hrs after injection
She had no immediate symptoms after vaccine but then presented to the Emergency Room and then approximate hour and a half later at 9:45 AM she noticed that she was having decreased sensation in her bilateral face left greater than right as well as on the ulnar aspect of her left arm (the side where she had the vaccine).   During her time emergency department, the patient symptoms did improve and by the end of her ED stay she was reporting almost no residual sensation deficits.
Patient intended to have Bivalent Pfizer booster and clinician inadvertently gave Monovalent Pfizer Covid vaccine
Headache began during the night after receiving vaccine. Headache progressively worse throughout the morning after peaking around noon. Headache continued all day after vaccine. Two days after vaccine I woke up with less of a headache. Headache remained mild for day two, three and four.  Day five headache is mild. This is date of reporting. Dizziness occurred during the night after vaccine. Extreme dizziness occurred the morning after and continued all day. Day two saw medium dizziness which prevented me from doing any activity beyond sitting.  Day three was better but dizziness persisted and prevented me from doing any activity involving movement for more than a short period. Day four was similar to day three. Day five is today and so far has been similar to day four. Arm at spot of injection was very sore the day after. Arm continued to be very sore for days two three and four preventing use of arm for lifting anything beyond lift weight items. Arm is still sore day five but more use if available though with pain.
Redness at injection site and spread 1-1.5 inches down arm. No symptoms other than muscle soreness
Pt recv vax & devel inj site rxn w/swelling,redness,warmth & pain. This is 1 of 5 pts that devel inj site rxn w/this same lot #.
Pt had a syncope episode right before leaving the clinic. Pt O/A for bumps/bruises. Eyes were PERRLA. Pt saw provider. Pt was offered emesis bag and water. Pt instructed to continue to lie down where she was in a safe area until she no longer felt dizzy and N/V, and increased strength. Pt was advised to increase fluid intake and food intake. Pt stated not eating very much and not drinking water that am.
pt recv vax 11FEB99 & pt devel vomiting & severe lethargy;pt hosp on 16FEB99 & treated w/IV saline & 5% dextrose in water;pt recovered;
Patient came into pharmacy at 10:00am to get a covid vaccine and asked for pfizer vaccine. It was his booster dose after the initial two-dose series.  Opened a new pfizer vaccine vial and instead of diluting the vial with normal saline, I pulled up 0.3mL to give to the patient. This is where the mistake occured. I gave 0.3mL of undiluted pfizer vaccine. Recognized administration error at 11:45 AM and called patient at 11:45AM to tell the patient the error occured, what the error was[too high a dose, possibly 5X recommended dose), and to be aware of any side effects that he may not have gotten from the first two-dose series since he is at higher risk of side effects. Patient reported that he was not having any issues or side effects at the current time but he would call us if he had any additional concerns or was having any side effects of concern.
Patient reports was outside gardening, arm felt itchy and she began scratching her upper left arm, and a welt began to appear and remains about 2 in in diameter. She believes that where the welt is where she received the vaccine. She reports no fever or feelings of sickness, and the itchy welt on her arm is the only symptom. Did not seek medical attention and will take an antihistamine that she has at home and report to MD if symptoms persist or worsen.
For 4 days - sore left arm; Sore left armpit; Swollen left armpit; 1 day - body aches; Headache; Dose received: 3; This is a spontaneous report from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 26Dec2021 at 14:00 (Lot number: FJ8762) at the age of 29 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: Penicillin. Concomitant medications included: MICROGESTIN; DAILY VITAMIN; ZINC and VITAMIN C. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EW0187, Anatomical Location: Left arm, Administration time: 16:00), administration date: 27May2021, when the patient was 29 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: EW0181, Anatomical Location: Left arm, Administration time: 16:00), administration date: 17Jun2021, when the patient was 29 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 26Dec2021 at 14:00, outcome "unknown", described as "Dose received: 3"; PAIN IN EXTREMITY (non-serious) with onset 26Dec2021 at 22:00, outcome "recovered" (30Dec2021), described as "For 4 days - sore left arm"; AXILLARY PAIN (non-serious) with onset 26Dec2021 at 22:00, outcome "recovered" (30Dec2021), described as "Sore left armpit"; SWELLING (non-serious) with onset 26Dec2021 at 22:00, outcome "recovered" (30Dec2021), described as "Swollen left armpit"; PAIN (non-serious) with onset 26Dec2021 at 22:00, outcome "recovered" (27Dec2021), described as "1 day - body aches"; HEADACHE (non-serious) with onset 26Dec2021 at 22:00, outcome "recovered" (27Dec2021), described as "Headache". Therapeutic measures were not taken as a result of pain in extremity, axillary pain, swelling, pain and headache.  Additional Information: The duration of the events PAIN and HEADACHE was reported as 1 day while that of the events PAIN IN EXTREMITY, AXILLARY PAIN, SWELLING was reported as 4 days. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.
No adverse effects were reported; The patient recieved one expired dose of VAQTA; This spontaneous report was received from an office manager, regarding 17 year old patient of unknown gender. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies and concomitant medications were not reported.   On 03-APR-2019, the patient was vaccinated with one expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) 25/0.5, intramuscular, lot number R010368, expiration date 25-MAR-2019, for prophylaxis. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA012081:
allergy like symptoms went away during the summer, but have come back this spring; body aches/muscle aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of SEASONAL ALLERGY (allergy like symptoms went away during the summer, but have come back this spring), MYALGIA (body aches/muscle aches) and PYREXIA (fever) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 030B21A) for COVID-19 vaccination.     The patient had not had seasonal allergies before receiving the Moderna vaccine.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced MYALGIA (body aches/muscle aches) and PYREXIA (fever). On an unknown date, the patient experienced SEASONAL ALLERGY (allergy like symptoms went away during the summer, but have come back this spring). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, SEASONAL ALLERGY (allergy like symptoms went away during the summer, but have come back this spring), MYALGIA (body aches/muscle aches) and PYREXIA (fever) outcome was unknown.            No concomitant medications were reported.   It was reported that, the patient took Tylenol, Advil, Aleve, and unspecified pain medications for his symptoms.   This case was linked to MOD-2022-571941 (Patient Link).
Vertigo-dizziness with  nausea, vomiting, diarrhea. Recovered. Blood pressure changes-high blood pressure. Headaches-recovered. Dizziness-not recovered.
red rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red rash at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (red rash at injection site). At the time of the report, VACCINATION SITE RASH (red rash at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.
Information has been received from a registered nurse concerning a 25 month old female patient with peanut, almond and egg allergy and no medical history on 22-MAY-2007 was vaccinated IM with a 0.5 ml dose of RECOMBIVAX HB (Lot # 654747/0039U). There was no concomitant medication. On 19-JUN-2007, 28 days after vaccination the patient developed widespread hives with slight itchiness. On 21-JUN-2007 the patient was seen by the physician who prescribed oral BENADRYL. At the time of report the patient had not recovered. No diagnostic laboratory test were undertaken. A product quality complaint was not involved. Additional information has been requested. Additional information was received from a registered nurse regarding the 25 month old female patient who developed hives and slight itchiness 28 days after being vaccinated with RECOMBIVAX HB indicating that on approximately 21-Jun-2007 the patient recovered from widespread hives with slight itchiness.
My husbands left arm was sore after the second shot; My husbands left arm was red after the second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (My husbands left arm was sore after the second shot) and VACCINATION SITE ERYTHEMA (My husbands left arm was red after the second shot) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A, 031L20A and 063E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (My husbands left arm was sore after the second shot) and VACCINATION SITE ERYTHEMA (My husbands left arm was red after the second shot). At the time of the report, VACCINATION SITE PAIN (My husbands left arm was sore after the second shot) and VACCINATION SITE ERYTHEMA (My husbands left arm was red after the second shot) outcome was unknown.            Concomitant  mediations were not reported.  Treatment history was not provided.
Pt bleed at injection site. Under skin. We talked about blood she immediately felt nauseated, was not pale but felt bad. She stayed seated, her son brought a cold item from fridge. She asked to lie down on floor, with ice on head and within 2 min said she felt better. Kept her for 10 min, Gatorade.
Immediate shock. Shoulder became very painful within a few hours. Over the subsequent days it got worse. I visited an urgent care doctor and was told I have a rotator cuff injury. It is still painful to this date.
Treatment of COVID-19; Treatment of COVID-19; Sneezing; stuffy nose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Mar2021 at 13:00 as dose number 2, single (Lot number: ENG206) at the age of 69 years, in left arm and on 04Oct2021 at 13:00 as dose number 3, (booster), single (Lot number: FD84218), in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), from 25Apr2022 at 13:00 (Lot number: 056M21A) to 25Apr2022 at 13:00 at single (dose number 4, (booster), single) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), (Batch/Lot number: unknown) at single (dose number unknown, single) for covid-19 immunisation. There were no concomitant medications. The following information was reported: SNEEZING (non-serious) with onset 06Jul2022 at 03:00, outcome "recovering"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Jul2022 at 03:00, outcome "unknown" and all described as "Treatment of COVID-19"; NASAL CONGESTION (non-serious) with onset 06Jul2022 at 03:00, outcome "recovering", described as "stuffy nose". The patient underwent the following laboratory tests and procedures: Blood pressure measurement: high. Therapeutic measures were taken as a result of drug ineffective, covid-19. Therapeutic measures were not taken as a result of sneezing, nasal congestion. Clinical course: Patient had no known allergies. Patient received Paxlovid for COVID 19 Treatment from 27Jun2022 to 02Jul2022.